SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Larimar Therapeutics officer acquires $13,549 in common shares

Chief Development Officer Gopi Shankar acquired Larimar Therapeutics common shares worth $13,549.

LRMR

Related stories